Inflammation and Prediction of Death in Type 2 Diabetes. Evidence of an Intertwined Link With Tryptophan Metabolism
The Journal of Clinical Endocrinology & Metabolism · 22.04.2025 · 110 (5) · e1323-e1333
DOI: 10.1210/clinem/dgae593 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 28.08.2024. Verfasst von Claudia Menzaghi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Diabetes and Endocrine Diseases, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico "Casa Sollievo della Sofferenza," 71…. Hauptthemen laut MEDLINE: Tryptophan, Diabetes Mellitus, Type 2, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione dell'Università, Ministero dell'Università, Heal Italia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
The role of inflammation in shaping death risk in diabetes is still unclear.
Objective
To study whether inflammation is associated with and helps predict mortality risk in patients with type 2 diabetes. To explore the intertwined link between inflammation and tryptophan metabolism on death risk.
Methods
There were 2 prospective cohorts: the aggregate Gargano Mortality Study (1731 individuals; 872 all-cause deaths) as the discovery sample, and the Foggia Mortality Study (490 individuals; 256 deaths) as validation sample. Twenty-seven inflammatory markers were measured. Causal mediation analysis and in vitro studies were carried out to explore the link between inflammatory markers and the kynurenine to tryptophan ratio (KTR) in shaping mortality risk.
Results
Using multivariable stepwise Cox regression analysis, interleukin (IL)-4, IL-6, IL-8, IL-13, RANTES, and interferon gamma–induced protein-10 (IP-10) were independently associated with death. An inflammation score (I score) comprising these 6 molecules is strongly associated with death in both the discovery and the validation cohorts HR (95% CI) 2.13 (1.91-2.37) and 2.20 (1.79-2.72), respectively. The I score improved discrimination and reclassification measures (all P < .01) of 2 mortality prediction models based on clinical variables. The causal mediation analysis showed that 28% of the KTR effect on mortality was mediated by IP-10. Studies in cultured endothelial cells showed that 5-methoxy-tryptophan, an anti-inflammatory metabolite derived from tryptophan, reduces the expression of IP-10, thus providing a functional basis for the observed causal mediation.
Conclusion
Adding the I score to clinical prediction models may help identify individuals who are at greater risk of death. Deeply addressing the intertwined relationship between low-grade inflammation and imbalanced tryptophan metabolism in shaping mortality risk may help discover new therapies targeting patients characterized by these abnormalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Unit of Diabetes and Endocrine Diseases, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico "Casa Sollievo della Sofferenza," 71013 San Giovanni Rotondo, Italy.
- Scientific Direction, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico "Casa Sollievo della Sofferenza," 71013 San Giovanni Rotondo, Italy.
- Metabolomics and Proteomics Core, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
- Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
- Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
- Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
ORCID-Profile: Claudia Menzaghi, Mario Mastroianno, Cornelia Prehn, Jerzy Adamski, Olga Lamacchia, Vincenzo Trischitta
Förderung
- Ministero dell'Istruzione dell'Università
- Ministero dell'Università
- Heal Italia
- Ministero della Salute
- Ricerca corrente
- European Health Data & Evidence Network
- Innovative Medicines Initiative 2 Joint Undertaking
- European Union's Horizon 2020 research and innovation program
Zitieren
APA
Menzaghi, C., Marucci, A., Mastroianno, M., Di Ciaccia, G., Armillotta, M. P., Prehn, C., Salvemini, L., Mangiacotti, D., Adamski, J., Fontana, A., De Cosmo, S., Lamacchia, O., Copetti, M., & Trischitta, V. (2025). Inflammation and Prediction of Death in Type 2 Diabetes. Evidence of an Intertwined Link With Tryptophan Metabolism. The Journal of Clinical Endocrinology & Metabolism, 110(5), e1323-e1333. https://doi.org/10.1210/clinem/dgae593
Vancouver
Menzaghi C, Marucci A, Mastroianno M, Di Ciaccia G, Armillotta MP, Prehn C, et al. Inflammation and Prediction of Death in Type 2 Diabetes. Evidence of an Intertwined Link With Tryptophan Metabolism. The Journal of Clinical Endocrinology & Metabolism. 2025;110(5):e1323-e1333. doi:10.1210/clinem/dgae593
BibTeX
@article{Menzaghi2025,
author = {Menzaghi, Claudia and Marucci, Antonella and Mastroianno, Mario and Di Ciaccia, Giulio and Armillotta, Maria Pia and Prehn, Cornelia and Salvemini, Lucia and Mangiacotti, Davide and Adamski, Jerzy and Fontana, Andrea and De Cosmo, Salvatore and Lamacchia, Olga and Copetti, Massimiliano and Trischitta, Vincenzo},
title = {Inflammation and Prediction of Death in Type 2 Diabetes. Evidence of an Intertwined Link With Tryptophan Metabolism},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {5},
pages = {e1323--e1333},
doi = {10.1210/clinem/dgae593}
}
EUVIMED